Surterra Wellness, an Atlanta-based cannabis company with operations in Florida and Texas, announced it will partner with Hungary’s Intrexon Corp. in a $100 million licensing deal aimed at biosynthetic cannabinoid production. Surterra would use Intrexon’s proprietary yeast fermentation platform to boost its cannabinoid production. Surterra is a privately held company; Intrexon trades on the Nasdaq […]
Surterra partners with Intrexon in $100 million licensing cannabinoid deal is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: Surterra partners with Intrexon in 0 million licensing cannabinoid deal
Comments are closed, but trackbacks and pingbacks are open.